mk0736
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2005 (NCT00274716)
Timeline
Indications
Mechanism of action
HSD11B1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mk0736
- mk-0736
- mk-0736
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00806585 | Phase 2 | Dec 1, 2008 | Merck |
| NCT00679055 | Phase 1 | Mar 31, 2007 | Foxhollow Technologies, Merck |
| NCT00274716 | Phase 2 | Nov 1, 2005 | Merck |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Merck | For profit | 3 | 3 | 2 | 2005 |
| Foxhollow Technologies | For profit | 1 | 0 | 1 | 2007 |
2 organizations
Page 1 / 1